Edition:
United States

MEI Pharma Inc (MEIP.OQ)

MEIP.OQ on NASDAQ Stock Exchange Capital Market

1.65USD
4:00pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.65
Open
$1.66
Day's High
$1.66
Day's Low
$1.63
Volume
2,613
Avg. Vol
26,006
52-wk High
$2.27
52-wk Low
$1.25

MEIP.OQ

Chart for MEIP.OQ

About

MEI Pharma, Inc. is an oncology company. The Company is focused on the clinical development of drugs and therapies for treatment of cancer. The Company's portfolio of clinical drug candidates includes Pracinostat, ME-344 and PWT143. Pracinostat is an orally available histone deacetylase (HDAC) inhibitor indicated for the... (more)

Overall

Beta: 1.19
Market Cap(Mil.): $60.31
Shares Outstanding(Mil.): 36.77
Dividend: --
Yield (%): --

Financials

  MEIP.OQ Industry Sector
P/E (TTM): 101.93 139.31 17.29
EPS (TTM): 0.02 -- --
ROI: 2.44 2.29 -5.84
ROE: 2.44 0.06 -5.23

BRIEF-MEI Pharma Inc files for mixed shelf of up to $150 million

* MEI Pharma Inc files for mixed shelf of up to $150 million Source text for Eikon: Further company coverage:

May 04 2017

BRIEF-MEI Pharma reports Q3 loss per share $0.02

* Q3 revenue $4.5 million Source text for Eikon: Further company coverage:

May 04 2017

BRIEF-Mei Pharma announces appointment of Brian Drazba as CFO

* Mei Pharma announces appointment of Brian Drazba as Chief Financial Officer Source text for Eikon: Further company coverage:

Apr 03 2017

BRIEF-MEI Pharma posts Q2 earnings per share $0.32

* MEI Pharma Inc - company believes its cash position will be sufficient to fund operations through at least fiscal year 2018 Source text for Eikon: Further company coverage:

Feb 08 2017

More From Around the Web

Earnings vs. Estimates